NYSE
402.43USD
-6.88 (-1.68%)
We have scored 56 news catalysts on Elevance Health Inc. (ELV) over the past 12 months. The biggest single-day move next to one of them came Mar 2, 2026, when ELV closed −8.1%: “Elevance Health Stock Sinks After CMS Freezes Medicare Advantage Enrollment”. Coverage across the window leans positive (average ticker sentiment +0.14). Most of the impact sits in sector healthcare and institutional appeal.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
87.3B
P/E
—
EPS
—
Beta
0.70
52W range
274.84-436.24
Day range
401.38–411.37
Open
410.88
Prev close
409.31
Volume
1.1M
Avg volume
1.4M
Dividend
6.87
IPO
2001-10-30
Analysts publish price targets on ELV, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
21 analyst price targets from $393 to $498
as of 2026-08-27
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Elevance Health Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of Elevance Health Inc., taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for ELV: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
The reconstruction
At $402, the stock sits at the 14th percentile of published models, leaning bearish against the analyst set and explicitly rejecting the nine bull cases that require margins to recover from their current trough.
What the disagreement turns on
Does the current 89.7% benefit expense ratio and 1.6% free-cash-flow margin represent a permanent structural impairment, or a temporary trough that will revert as risk adjustments flow through? The wired data can measure Carelon's unit volume trajectory but cannot measure the pricing and risk-adjustment dynamics that will actually settle the margin question.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
